106 related articles for article (PubMed ID: 29552753)
1. The impact of multiple primary neoplasms in daily practicea systematic review of the literature.
Nemes A; Nagy V
J BUON; 2018; 23(1):14-18. PubMed ID: 29552753
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics of patients with multiple primary neoplasms-a retrospective analysis.
Nemes A; Todor N; Nagy V
J BUON; 2018; 23(6):1846-1854. PubMed ID: 30610812
[TBL] [Abstract][Full Text] [Related]
3. Follow-up protocol for oncological patients at risk of developing multiple primary neoplasms.
Nemes A; Todor N; Nagy V
J BUON; 2020; 25(4):2117-2122. PubMed ID: 33099962
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.
De Luca A; Frusone F; Vergine M; Cocchiara R; La Torre G; Ballesio L; Monti M; Amabile MI
In Vivo; 2019; 33(4):1313-1324. PubMed ID: 31280224
[TBL] [Abstract][Full Text] [Related]
5. [Impact of diagnosis and treatment of early stage secondary tumors on outcome for the oncologic ORL patient].
Grosjean P; Monnier P
Schweiz Med Wochenschr Suppl; 2000; 116():43S-46S. PubMed ID: 10780070
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors.
Lv M; Zhang X; Shen Y; Wang F; Yang J; Wang B; Chen Z; Li P; Zhang X; Li S; Yang J
Medicine (Baltimore); 2017 Apr; 96(17):e6799. PubMed ID: 28445321
[TBL] [Abstract][Full Text] [Related]
7. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
8. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.
Powell S; Tarchand G; Rector T; Klein M
Cancer Causes Control; 2013 Aug; 24(8):1565-73. PubMed ID: 23737025
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
[TBL] [Abstract][Full Text] [Related]
11. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis.
Jiang L; He J; Shi X; Shen J; Liang W; Yang C; He J
Lung Cancer; 2015 Mar; 87(3):303-10. PubMed ID: 25617985
[TBL] [Abstract][Full Text] [Related]
13. Role of routine panendoscopy in cancer of the upper aerodigestive tract.
Stoeckli SJ; Zimmermann R; Schmid S
Otolaryngol Head Neck Surg; 2001 Feb; 124(2):208-12. PubMed ID: 11226943
[TBL] [Abstract][Full Text] [Related]
14. Multiple primary malignant neoplasms in urologic patients.
Koyama K; Furukawa Y; Tanaka H
Scand J Urol Nephrol; 1995 Dec; 29(4):483-90. PubMed ID: 8719367
[TBL] [Abstract][Full Text] [Related]
15. [Synchronous and metachronous myeloid and lymphoid tumors].
Melikian AL; Kolosheĭnova TI; Goriacheva SR; Subortseva IN; Vakhrusheva MV; Kolosova EN; Sudarikov AB; Abdullaev AO; Dvirnyk VN; Varlamova EIu; Kovrigina AM; Turkina AG
Ter Arkh; 2014; 86(7):37-44. PubMed ID: 25314776
[TBL] [Abstract][Full Text] [Related]
16. Extremely rare synchronous primary neoplasms in testicular cancer patients.
Mrinakova B; Ondrusova M; Lehotska V; Ondrus D
Bratisl Lek Listy; 2019; 120(9):641-645. PubMed ID: 31475546
[TBL] [Abstract][Full Text] [Related]
17. [Multiple primary malignancies].
Bisof V; Basić-Koretić M; Juretić A; Krpan AM; Samardić KR; Rakusić Z; Santek F; Krajina Z; Podolski P; Sarić N; Crnjević TB
Lijec Vjesn; 2011; 133(11-12):384-8. PubMed ID: 22329294
[TBL] [Abstract][Full Text] [Related]
18. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
[TBL] [Abstract][Full Text] [Related]
19. Synchronous and metachronous breast cancer in Ukraine.
Motuzyuk I; Sydorchuk O; Kovtun N; Kostiuchenko Y
Breast Dis; 2017; 37(2):83-93. PubMed ID: 29504518
[TBL] [Abstract][Full Text] [Related]
20. Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.
Tamjid B; Phan P; John T; Mitchell P; Gan H
Head Neck; 2017 Aug; 39(8):1544-1549. PubMed ID: 28593651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
